Antioxidant Properties of Adrenaline in the Presence of Ge-132 by Filonova, G.E. et al.
COMMUNICATION 
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Abstract: Using cyclic voltammetry, UV and 1H NMR spectroscopy, 
we have investigated the effect of 2-carboxyethylgermanium (Ge-
132), the most common germanium-containing dietary supplement, 
on the antioxidant activity of adrenaline in aqueous solutions. The 
complex formed by adrenaline and Ge-132 is oxidizable at 400 mV 
more positive potentials compared to non-coordinated adrenaline 
which corresponds to its 9 kcal/mol more difficult oxidation. An 
equilibrium constant of the complex formation was estimated (1300 
M-1). It was shown that at the concentrations <10–3 M the complex 
Ge-132-adrenaline is mostly dissociated to the initial compounds, 
and the influence of Ge-132 on the antioxidant properties of 
adrenaline becomes significant only when the former is in an excess. 
Considering that such concentrations are typical for physiological 
conditions, this fact can be significant in identifying the mechanism 
of the biological action of Ge-132 and its interference with the 
biological catechols.  
Introduction 
Catechols are a broad group of organic compounds containing 
1,2-dihydroxyphenyl moiety. On the one hand, such an easily 
oxidizable structure forms a large group of antioxidants both of 
vegetable and of physiological origin [1] involved in regulating 
the formation of reactive oxygen species. On the other hand, the 
possibility of binding of metal cations and metalloids with the 
hydroxyl groups with the formation of stable complexes causes a 
rich coordination chemistry of these compounds. Of course, the 
presence of various metals can also affect the antioxidant 
properties of biologically active catechols [1a]. In humans and 
animals, catechols can play the role of metabolites in the 
decomposition of estrogens [2], transmitters (eg, adrenaline, 
norepinephrine, etc.) [3] etc. These processes are also often 
associated with the specific behavior of the 1,2-diol fragment.  
Among the biogenic catechols, adrenaline is widely known. It is 
the first hormone synthesized and structurally characterized in 
1904 [4]. There is a lot of papers, reviews and patents devoted 
to the study of adrenaline oxidation under the action of various 
metal ions. The earliest one describes the adrenaline 
complexation with bivalent metal ions Zn2+, Cd2+, Ni2+ etc. [5]  
Recently, our group has shown that adrenaline antioxidant 
activity significantly decreases (by one order of magnitude) 
compared to that of the initial adrenaline when it is complexed 
with germanium dioxide [6] (scheme 1). Germanium is a 
physiologically active microelement, heavier group 14 carbon 
analog with a stable tetravalent state. A distinctive feature of 
germanium dioxide, in particular in comparison with silicon, is 
the ability to interact reversibly with catechols under mild, close 
to physiological, conditions [7].  
Scheme 1. Formation of the complex of germanium dioxide with adrenaline. 
By replacing one of the four valences in germanium dioxide with 
a carboxyethyl function, it is possible to obtain its sesquioxide — 
a widely used and intensively studied biologically active drug 
commercially known as Ge-132 (scheme 2) [8]. Its various 
spectrum of activity (including antioxidant) is discussed, [8c], 
however our results have shown that under physiological 
conditions Ge-132 can act as an antioxidant mainly in lipid 
phase in contrast to aqueous media where this activity 
significantly decreases (scheme 2) [8d]. 
Scheme 2. Antioxidant active (lipid) and non-active (water) forms of Ge-132.  
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Moreover, in its water-soluble monomeric triol form, Ge-132 is 
able to interact with a number of physiological substances: 
nucleic acids [8c], monosaccharides [9] etc. Recently a complex 
of adrenaline with Ge-132 (scheme 3) have been isolated and 
structurally characterized [10]. By analogy with the complex of 
adrenaline with GeO2, adrenaline-Ge-132 adduct could be 
expected to have a reduced antioxidant activity relative to the 
initial adrenaline. In addition, the adduct stability is important 
under high dilution (physiological conditions). Given the 
importance of adrenaline in many life-related processes, the 
present work aims to elucidate this important point. 
Scheme 3. Formation of the complex of Ge-132 with adrenaline. 
Results and Discussion 
The methods of 1H NMR and UV-vis spectroscopy, as well as 
cyclic voltammetry, are widely used for the study of 
complexation in solutions [11]. The two latter methods are also 
used to test antioxidant activity, for example, by evaluating the 
kinetics of DPPH color disappearance in the reaction with a 
potential antioxidant (UV-vis spectroscopy [12]) or directly 
considering the oxidation potential change of the antioxidant 
determined using voltammetry [13]. Remarkably, these three 
methods deal with contiguous but different concentration ranges 
allowing to study the equilibrium processes by independent 
methods well as to evaluate it in a wide range of concentrations. 
The results of detailed study of the complexation of Ge-132 with 
adrenaline in a phosphate buffer solution of close to 
physiological acidity will be presented below. 
1ɇ NMR spectroscopy 
The 1H spectrum of Ge-132 in a phosphate buffer solution (pH = 
6.86) at a concentration of 1.3Â10-1 M  (Fig.  1a)  contains  two
triplets (1.04 and 1.94 ppm) belonging to CH2-CH2 fragments of 
the molecule. 1H NMR experiment with similar concentrations of 
adrenaline in aqueous solution is difficult due to the low solubility. 
When both compounds are present at the same concentrations, 
the methylene proton signals of Ge-132 shift to 1.30 and 2.04 
ppm, respectively (Fig. 1b) corresponding to the complex 
formation (the equilibrium on Scheme 3 being shifted to the right 
side). At the same time, along with the complex signals, low-
intensity peaks from the protons of unreacted Ge-132 are 
observed. However, the integral value of these signals relative to 
the intensity of the corresponding peaks is about 1% only. 
Diluting the reactants 10 times (up to 1.3u10-2 M) causes 
increasing the intensity of the peaks related to the protons of 
non-coordinated Ge-132 on its 1H  NMR  spectrum  (Fig.  1c).
These changes indicate the complex dissociation (the 
equilibrium shifting to the left). A similar tendency is observed  
Figure 1. Fragments of 1ɇ NMR spectra of a) Ge-132; b-d) mixture of Ge-132 
and adrenaline in ɇ2Ɉ. Concentrations: b) 1.38u10-1Ɇ; c) 1.3u10-2Ɇ; d) ~10-3 
Ɇ. 
for further dilution (Fig. 1d). A series of the experiments in the 
concentration range 10–1 – 10–3 M allowed us to determine the 
equilibrium constant of reaction depicted on scheme 3 according 
to the Ostwald’s dilution law as K = 1300±70 M-1. 
At the dilution limit, allowing determining quantitatively the 
equilibrium components of the reaction using 1H NMR 
spectroscopy (~10–3 M), the dissociated and non-dissociated 
forms of the complex are present in comparable amounts. It 
should be noted that this is a typical concentration used in cyclic 
voltammetry. 
Cyclic voltammetry 
The CV curve of adrenaline solution (2u10-3 M) in phosphate 
buffer (pH = 6.86) at a glassy carbon working electrode is shown 
in Fig. 2a. It is seen that its oxidation corresponds to a 
chemically irreversible peak at 0.51 V, and on the reverse scan 
there is a peak of reduction of adrenalin-quinone (the product of 
adrenaline oxidation) [14]. Such an easy oxidation of adrenaline 
reveals its strong antioxidant properties. 
At the same time, hampering the adrenaline antioxidant 
properties following the formation of the complex should 
correspond to the oxidation peak potential shift to more positive 
values in the presence of a binding reagent. Indeed, the addition  
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Figure 2. (a) Oxidation of adrenaline (2u10-3Ɇ, red curve), (b) adrenaline-Ge-
132 mixture (2u10-3 Ɇ +  3u10-3 Ɇ, green curve); (c) adrenaline-Ge-132 
mixture (2u10-3Ɇ + 6u10-3Ɇ, black curve) and d) adrenaline-Ge-132 mixture 
(2u10-3Ɇ + 9u10-3Ɇ, blue curve) at a glassy carbon (GC) disk electrode (d = 
1.7 mm) in phosphate buffer (pH = 6.86). Scan rate v = 0.1 V s-1. T = 298 Ʉ.  
of 3u10-3 M Ge-132 to the adrenaline solution is accompanied by 
the appearance of a new chemically irreversible peak at 0.91 V 
(Fig. 2b) corresponding to 9.22 kcal/mol more difficult oxidation. 
However, despite the 1.5-fold excess of Ge-132, the oxidation of 
non-bonded adrenaline (high “shoulder” at ~ 0.51 V) is still 
observed on the CV curve (its current comparable to the current 
of the complex). It indicates that only part of adrenaline in 
solution decreases antioxidant properties. Increasing the Ge-132 
concentration to 6Â10-3 M (3-fold excess, Fig. 2c) provokes the 
decrease of this arm and a relative increase of the current of the 
oxidation peak of the complex. In the presence of 9u10-3 M Ge-
132 (4.5-fold excess, Fig. 2d), non-bonded adrenaline in solution 
is almost invisible and only Ge-132-adrenaline complex is 
observed. This feature reflects weakr antioxidant properties of 
the Ge-132-adrenaline complex compared to adrenaline. 
Thus, the data of voltammetry correlate well with the NMR 
results. It was shown that in the concentration range ~ 10–3 M, 
the complex of Ge-132-adrenaline is largely dissociated (the 
equilibrium 3 is noticeably shifted to the left). The complex has 
thus significantly reduced antioxidant properties compared to the 
initial adrenaline. An excess of Ge-132 is required for complex 
formation. 
UV-Vis spectrophotometry 
The standard method of assessing the antioxidant activity and of 
comparing the potential antioxidants between them is 
considering their interaction with a stable free radical 
diphenylpicrylhydrazyl (DPPH) [12]. Moreover, due to the 
intense color of DPPH in its free form, spectrophotometry is a 
convenient method to follow the reaction of a potential 
antioxidant with DPPH. Such interactions are monitored by 
disappearance of the DPPH color. A more intensive 
Figure 3. UV-vis spectra of DPPH (1u10-4Ɇ, black) in phosphate buffer (pH = 
6.86) in the presence of equimolar amount of adrenaline (1u10-4Ɇ, blue) and 
adrenaline-Ge-132 mixture (1u10-4Ɇ + 1Â10-4Ɇ, red) after (upper) 10 sec and 
(lower) 60 sec.  
discoloration of DPPH will correspond to a higher antioxidant 
activity of the substrate tested. The typical concentrations used 
in spectrophotometry are 10-4 M and below. According to 1H 
NMR spectroscopy and cyclic voltammetry, dealing with one 
order of magnitude higher concentrations and even more 
concentrated solutions, it was possible to assume that in this 
case the effect of Ge-132 on the antioxidant properties of 
adrenaline would be decreased. The UV spectra of 1u10–4 M 
DPPH in phosphate buffer pH = 6.86 are presented in fig. 3 
(black line). Its intense color corresponds to the ʌ – ʌ* transition 
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at 520 nm. In the presence of an equimolar amount of 
adrenaline, this peak decreases many times within 10 seconds 
(Fig. 3, upper, blue line) and becomes hardly noticeable after 60 
seconds (Fig. 3, lower, blue line). Taking into account that the 
UV-spectroscopic method of evaluating the antioxidant activity of 
a potential antioxidant is based on the estimation of DPPH 
absorption 30 minutes after mixing them, this is evidence of very 
strong antioxidant properties of adrenaline. The experiment 
performed with adrenaline in the presence of Ge-132 (Fig. 3, red 
lines) shows almost completely identical results without any 
noticeable inhibition of the interaction of catechol with the free 
radical. 
Conclusions 
The data of 1H NMR spectroscopy, cyclic voltammetry and UV 
spectrophotometry show that the complex of adrenaline and 
carboxyethylgermanium Ge-132 has significantly reduced 
antioxidant properties compared to the initial adrenaline. 
However, dilution of the solution of this complex in aqueous 
media to the concentrations of 10–4 M or lower causes its 
dissociation, and the effect of Ge-132 on the antioxidant 
properties of the catechol cannot be detected anymore. 
In general, the hydrolyzed form of Ge-132 in water solution can 
be considered as a structural analogue of Ȗ-aminobutyric acid 
containing a germane-triol fragment capable to reversible 
complexation and chelation with a number of organic (in 
particular, 1,2-diols) and inorganic molecules. Undoubtedly, in 
many cases various aspects of biological activity of Ge-132 
(extensively discussed in the literature) may be associated with 
this phenomenon. To our opinion - taking into account that the 
complexes of Ge-132 with catechols have been characterized by 
various spectral methods (including X-ray crystallography), - 
substantial diversion of the essential reactions of biological 
catechols in the presence of Ge-132 should be carefully 
considered. 
Experimental Section 
Adrenaline (epinephrine) was purchased from Aldrich and used without 
further purification. DPPH (Fluka) was used as received. Ge-132 has 
been prepared from HGeCl3 and ethyl acrylate according to ref. [15]. 
Phosphate buffer solutions (pH = 6.86) were purchased from Ecroskhim 
and dissolved in 1 L of distilled water before use. Thus prepared solution 
contained 3.389 g of KH2PO4 and 3.533 g of Na2HPO4. 
1H NMR (300 MHz) spectra were recorded on Bruker AV300 in H2O at 
ambient temperature. UV-Vis spectra were registered using Agilent 8453 
instrument using a 10 mm quartz cell. Cyclic voltammetry was carried out 
using a PC-piloted digital potentiostat IPC-Pro-MF (Econix). A standard 
thermostated (T = 25 ± 0.5 °ɋ) 10 ml electrochemical cell was used in a 
three-electrode configuration. As a working electrode, GC (1.7 mm) disk 
was used, polished before each run; a Pt wire was used as an auxiliary 
electrode. The potentials are referred to the AgCl/KClsat electrode 
separated from the analyte by an electrolytic bridge filled with the same 
solution. All measurements were carried out under dry argon. 
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